RxDoctor Payments Data

Christina James

Nurse Practitioner · Rogers, ARNPI 1144496894

Payments from drug & device makers

$2,793in general payments, 2019–2025

Across 185 payments — averaging $15.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$765
  • Pfizer$293
  • Medtronic$260
  • Abbott$259
  • Amgen$198
  • Johnson & Johnson$173
  • plus $846 from 19 others

What the payments were for

  • Food & beverage$2,793100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,793 in reported general payments places this provider in the 85th percentile of 697 nurse practitioner providers in Arkansas.

See all nurse practitioner providers in Arkansas

Medicare billing

Part B allowed, 2024
$22,613
Medicare patients
196
Services billed
227

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban160$148,108
EntrestoSacubitril/Valsartan49$55,700
Repatha SureclickEvolocumab51$41,942
OzempicSemaglutide27$26,549
WegovySemaglutide19$25,478
XareltoRivaroxaban17$12,637
JardianceEmpagliflozin12$9,758
Ranolazine ErRanolazine92$6,468
Dofetilide12$4,130
Metoprolol Succinate264$3,196
ClopidogrelClopidogrel Bisulfate287$2,819
Rosuvastatin Calcium233$2,243
Ezetimibe79$1,770
Digoxin70$1,473
Torsemide101$1,320

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$293$148,108160 claims
NovartisEntresto$765$55,70049 claims
Novo NordiskOzempic, Wegovy$16$52,02746 claims
Johnson & JohnsonXarelto$173$12,63717 claims
Boehringer IngelheimJardiance$53$9,75812 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 697 nurse practitioner providers in Arkansas.

Other nurse practitioner in Rogers

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →